NHE-RF, a merlin-interacting protein, is primarily expressed in luminal epithelia, proliferative endometrium, and estrogen receptor-positive breast carcinomas.
about
Direct interaction between NHERF1 and Frizzled regulates β-catenin signalingNHERF1/EBP50 controls morphogenesis of 3D colonic glands by stabilizing PTEN and ezrin-radixin-moesin proteins at the apical membraneBreast cancer-derived K172N, D301V mutations abolish Na+/H+ exchanger regulatory factor 1 inhibition of platelet-derived growth factor receptor signalingRegulation of G protein-coupled receptor function by Na+/H+ exchange regulatory factorsStructural determinants of the Na+/H+ exchanger regulatory factor interaction with the beta 2 adrenergic and platelet-derived growth factor receptorsMerlin, a "magic" linker between extracellular cues and intracellular signaling pathways that regulate cell motility, proliferation, and survivalTargeted disruption of the mouse NHERF-1 gene promotes internalization of proximal tubule sodium-phosphate cotransporter type IIa and renal phosphate wastingEzrin and EBP50 redistribute apically in rat uterine epithelial cells at the time of implantation and in response to cell contactProton, diffusion-weighted imaging, and sodium (23Na) MRI of uterine leiomyomata after MR-guided high-intensity focused ultrasound: a preliminary study.The NHERF1 PDZ2 domain regulates PKA-RhoA-p38-mediated NHE1 activation and invasion in breast tumor cells.NHERF1/EBP50 is an organizer of polarity structures and a diagnostic marker in ependymomaProteomic analysis of MCF-7 breast cancer cell line exposed to mitogenic concentration of 17beta-estradiol.NHERF-1: modulator of glioblastoma cell migration and invasionSystematic family-wide analysis of sodium bicarbonate cotransporter NBCn1/SLC4A7 interactions with PDZ scaffold proteinsNHERF1/EBP50 in Breast Cancer: Clinical PerspectivesMelasma: a clinical and epidemiological reviewExpanding the role of NHERF, a PDZ-domain containing protein adapter, to growth regulation.NHERF1/EBP50 is a new marker in colorectal cancer.Development and validation of a gene expression score that predicts response to fulvestrant in breast cancer patientsSuppression of breast cancer cell growth by Na+/H+ exchanger regulatory factor 1 (NHERF1)Statistical considerations for immunohistochemistry panel development after gene expression profiling of human cancers.Drug Transporters and Na+/H+ Exchange Regulatory Factor PSD-95/Drosophila Discs Large/ZO-1 ProteinsNHERF1 acts as a molecular switch to program metastatic behavior and organotropism via its PDZ domains.Prognostic significance of peroxiredoxin 1 and ezrin-radixin-moesin-binding phosphoprotein 50 in cholangiocarcinoma.The potential predictive role of nuclear NHERF1 expression in advanced gastric cancer patients treated with epirubicin/oxaliplatin/capecitabine first line chemotherapy.NHERF1/EBP50 controls lactation by establishing basal membrane polarity complexes with prolactin receptor.Temporal and spatial regulation of ezrin-radixin-moesin-binding phosphoprotein-50-kDa (EBP50) during embryo implantation in mouse uterus.Deletion of Na+/H+ exchanger regulatory factor 2 represses colon cancer progress by suppression of Stat3 and CD24.Ezrin-radixin-moesin-binding phosphoprotein (EBP50), an estrogen-inducible scaffold protein, contributes to biliary epithelial cell proliferationmiR-8 microRNAs regulate the response to osmotic stress in zebrafish embryosNHERF1/EBP50 Suppresses Wnt-β-Catenin Pathway-Driven Intestinal Neoplasia.Nuclear NHERF1 expression as a prognostic marker in breast cancer.Ezrin-radixin-moesin-binding phosphoprotein 50 (EBP50) and nuclear factor-κB (NF-κB): a feed-forward loop for systemic and vascular inflammation.Na+-H+ exchanger regulatory factor 1 is a PDZ scaffold for the astroglial glutamate transporter GLAST.NHERF1, a novel GPER associated protein, increases stability and activation of GPER in ER-positive breast cancer.Role of the PDZ-scaffold protein NHERF1/EBP50 in cancer biology: from signaling regulation to clinical relevance.Tumor suppressor function of ezrin-radixin-moesin-binding phosphoprotein-50 through β-catenin/E-cadherin pathway in human hepatocellular cancer.Loss of EBP50 stimulates EGFR activity to induce EMT phenotypic features in biliary cancer cells.New functions for the NHERF family of proteins.Quantitative assessment of tissue biomarkers and construction of a model to predict outcome in breast cancer using multiple imputation
P2860
Q24298046-6BE2A995-2866-471D-9C71-A70DE682B7CAQ24298305-DF8F8887-16A0-412C-BC98-468A29E009E0Q24323184-F235CBFF-B003-494C-BF56-113ACEA8332EQ26863645-BF9A0C35-7BB1-4E32-BB87-9A3166D2FCE3Q27638205-359A391F-82A6-4043-8FEF-0A9AE1966BBEQ28283076-DA1B620B-3D93-468F-98B2-D5EF91888CE7Q28510488-9CC122CA-6CC4-4E1F-92ED-659972BE0B82Q28575379-5649A0F5-AA2D-47AE-902A-93B8C4DFB259Q30431628-2C6D3CC8-8C71-4ECE-985C-387AA89E24FAQ30479321-2958FA65-2A58-4EB1-B864-6F299614DB44Q30625458-BDC3939A-DC99-4681-B9C7-5B831A0DA252Q33260890-278BC714-9107-4A96-BBB2-1516644B48B9Q33420852-0EBABFA5-8CBD-43B7-BC03-2A889C2821DFQ33902906-4F613084-8764-413A-B19A-F13F524C41AFQ34096013-098D0E5E-C9A4-46A7-9D88-4B58D013179EQ34140514-84A83354-7990-4CA9-B9F3-2844C944A488Q34405532-B070B3DD-1756-413E-B42C-00AB5AC1293EQ34411711-CECFC82D-4EF5-441B-BCB0-C355C639B70FQ35088147-85621855-12B9-426D-898E-E640BF18B37BQ35633702-E9936738-7008-4F9E-B8D3-565594D6613DQ35789866-DE8D7D0B-7886-42C0-983B-37E32B79CB86Q35795744-6F552DEF-E737-43B5-890E-BABE3333681CQ35998570-C3126380-4EE7-41F1-B138-328A293F0D54Q36066974-CA643457-43A8-4758-B610-864EC92CFBCDQ36214152-B09BB55E-C843-4E13-8F26-51AC8DD6365BQ36288731-D2DF1D4F-156F-4320-A7AF-F3156E46D34BQ36538416-35E387C6-A1FB-4601-81A3-A221EB2A2871Q36811339-8301AA44-B6AB-4F26-9AD5-8CAC9352793EQ37150777-75B084B5-99AC-4A8C-B0E1-CE0FC9673B29Q37237885-1095D086-0369-451B-BB21-AE9CA820EC31Q37246058-C443D488-4862-46C0-B8A9-D1CF1B9880E3Q37357067-2DF0F77C-4FAE-45A1-93FE-35683A693A09Q37405006-A80EFD3B-6656-4C25-A38B-99BAF89772AAQ37412617-E1AB24D3-F067-433F-9C98-8081BE546714Q37688175-3C46D3A2-B670-4580-BDA7-8B26A99E2EC2Q39076960-FF7EBAD1-5DD2-4CE4-8780-B6EEB29109FDQ39181929-7E732D8F-9D2B-4724-8416-C731833E9737Q39493807-690252CC-B6EE-4741-8C9C-2D5019E8A1A7Q39921311-7F58D5F6-7037-40EC-96F6-5A281FE0CACAQ39989109-C9FF408B-C31F-4E90-AEF0-36D9C64C1119
P2860
NHE-RF, a merlin-interacting protein, is primarily expressed in luminal epithelia, proliferative endometrium, and estrogen receptor-positive breast carcinomas.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
2001年论文
@zh
2001年论文
@zh-cn
name
NHE-RF, a merlin-interacting p ...... or-positive breast carcinomas.
@ast
NHE-RF, a merlin-interacting p ...... or-positive breast carcinomas.
@en
type
label
NHE-RF, a merlin-interacting p ...... or-positive breast carcinomas.
@ast
NHE-RF, a merlin-interacting p ...... or-positive breast carcinomas.
@en
prefLabel
NHE-RF, a merlin-interacting p ...... or-positive breast carcinomas.
@ast
NHE-RF, a merlin-interacting p ...... or-positive breast carcinomas.
@en
P2093
P2860
P1476
NHE-RF, a merlin-interacting p ...... or-positive breast carcinomas.
@en
P2093
A O Stemmer-Rachamimov
D Pinney-Michalowski
G P Nielsen
T Wiederhold
P2860
P356
10.1016/S0002-9440(10)63944-2
P407
P577
2001-01-01T00:00:00Z